Los Angeles Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-24,947
| Closed | -$297K | – | 1494 |
|
|
2022
Q1 | $297K | Sell |
24,947
-822
| -3% | -$9.79K | ﹤0.01% | 1243 |
|
|
2021
Q4 | $840K | Sell |
25,769
-125
| -0.5% | -$4.08K | ﹤0.01% | 786 |
|
|
2021
Q3 | $1.16M | Sell |
25,894
-1,257
| -5% | -$56.2K | 0.01% | 710 |
|
|
2021
Q2 | $1.48M | Buy |
27,151
+18,113
| +200% | +$987K | 0.01% | 684 |
|
|
2021
Q1 | $676K | Sell |
9,038
-2,495
| -22% | -$187K | ﹤0.01% | 1083 |
|
|
2020
Q4 | $1.25M | Buy |
11,533
+901
| +8% | +$97.7K | 0.01% | 838 |
|
|
2020
Q3 | $940K | Buy |
10,632
+2,321
| +28% | +$205K | ﹤0.01% | 846 |
|
|
2020
Q2 | $886K | Buy |
8,311
+3,627
| +77% | +$387K | ﹤0.01% | 894 |
|
|
2020
Q1 | $278K | Buy |
4,684
+3,564
| +318% | +$212K | ﹤0.01% | 1079 |
|
|
2019
Q4 | $77K | Buy |
+1,120
| New | +$77K | ﹤0.01% | 1243 |
|
|
2019
Q3 | – | Sell |
-4,037
| Closed | -$374K | – | 1387 |
|
|
2019
Q2 | $374K | Sell |
4,037
-1
| -0% | -$93 | ﹤0.01% | 1118 |
|
|
2019
Q1 | $369K | Buy |
4,038
+310
| +8% | +$28.3K | ﹤0.01% | 1152 |
|
|
2018
Q4 | $208K | Sell |
3,728
-35
| -0.9% | -$1.95K | ﹤0.01% | 1198 |
|
|
2018
Q3 | $448K | Sell |
3,763
-2,226
| -37% | -$265K | ﹤0.01% | 1126 |
|
|
2018
Q2 | $611K | Buy |
+5,989
| New | +$611K | ﹤0.01% | 1076 |
|